We observed an increasing trend in IL-10 production 12 months post switching in both treatment groups ( Figure 2(a) ).
← all excerpts
Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis.
1
—
—